Skip to main content

Jeff Lagasse

By Jeff Lagasse | 11:53 am | November 06, 2023
Lawmakers are concerned that CMS' 2024 final Part C and D rule may not adequately address MA plans' increased reliance on AI.
By Jeff Lagasse | 03:14 pm | November 03, 2023
Premier and the American Hospital Association laud a recent Supreme Court decision but say HHS is still acting unlawfully.
By Jeff Lagasse | 11:47 am | November 03, 2023
The three in five people who were offered and who accessed their online record or patient portal last year was a 50% increase over 2020.
By Jeff Lagasse | 10:15 am | November 03, 2023
The company cites clinical expertise and service capabilities across the company, boosted by "disciplined execution."
By Jeff Lagasse | 10:36 am | November 02, 2023
Doctors' Management Services failed to determine the potential risks and vulnerabilities in the breach, HHS says.
By Jeff Lagasse | 03:22 pm | November 01, 2023
A number of factors contributed to the company's financial performance, including the August launch of Cordavis and its MA offerings.
By Jeff Lagasse | 10:38 am | November 01, 2023
Nostrum admitted it acquired Nitro OS from another manufacturer and continued to market it based on its preexisting FDA approval.
By Jeff Lagasse | 06:26 pm | October 31, 2023
Lack of transparency limits the ability of regulators to monitor prices and of employers and patients to impose market discipline on prices.
By Jeff Lagasse | 10:10 am | October 31, 2023
Final rule increases payment for certain new renal dialysis drugs and biological products.
By Jeff Lagasse | 03:32 pm | October 27, 2023
The larger ACA plan footprint will bring access to affordable benefits to more than 60% of the eligible population, UHC says.